ArticleArchives of medical science : AMS2022

Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life.

Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.